Study on Endora's Women's Supplement
Claim 1
At the Endpoint (Cycle 2 Day 7): 70% of participants agreed that their heavy flows have reduced since using the test product.
Claim 2
At the Endpoint (Cycle 2 Day 7): 64% of participants agreed that their pelvic pain has been less severe since using the test product.
Claim 3
At the Endpoint (Cycle 2 Day 7): 64% of participants agreed that they experienced less frequent painful bowel movements since using the test product.
About
Endora
Endora is a women’s health brand dedicated to improving quality of life through targeted, research-driven solutions. With a deep understanding of the challenges faced by women with endometriosis, Endora’s mission is to deliver effective, clinically informed products that address real symptoms, and help women reclaim control of their health.
What is Endora’s Women’s Supplement?
Endora Women’s Supplement is a daily liquid formula designed to support women living with endometriosis. Formulated to reduce inflammation, support hormonal balance, and target key symptoms such as pelvic pain, bloating, and heavy flow, this supplement brings together evidence-backed ingredients in a convenient, once-daily dose. The product was developed with the goal of improving quality of life for those impacted by endometriosis, and was evaluated in a recent clinical study to assess its real-world impact.
Study Design for
Endora
A single-group clinical trial was conducted to evaluate the effects of the Endora Women’s Supplement on common endometriosis symptoms.
Participants: 20 women aged 18–40, all experiencing severe menstrual cramps
Duration: One menstrual cycle plus the following menstruation
Design: Participants took 2 mL of the product daily and completed symptom assessments throughout the study
Assessments Included:
The Endometriosis Health Profile (EHP) – a validated questionnaire
A study-specific questionnaire targeting ten key symptoms
A product perception survey evaluating user experience
Data was statistically analyzed using standardized methods (T-tests and ANOVA), with significance set at p<0.05.
Study Results for
Endora
Significant Symptom Improvements Over One Cycle
The study showed measurable and meaningful improvements across several endometriosis-related symptoms:
Symptom-Specific Outcomes
At the end of the study (Cycle 2, Day 7), participants experienced significant improvements in:
Pelvic pain severity ↓ 34–42%
Bloating frequency ↓ 34.34%
Painful bowel movements ↓ 36%
Heavy flow symptoms ↓
Menstrual cramp frequency ↓ 38.38%
Bleeding through tampon/pad in under 2 hours ↓
Improvements observed as early as Week 1, with cumulative gains over 4 weeks
Participant Feedback Highlights
At study end, participant agreement (≥50%) included:
64.7% reported less severe pelvic pain
64.7% reported less frequent painful bowel movements
70.6% reported reduced heavy flow
52.9% noted improved mood and emotional balance
76.5% said they would continue using the product
76.5% would recommend it to family or friends
Benefits of Clinical Research
Scientific validation is essential in women’s health, especially for complex conditions like endometriosis, where symptoms can be multifaceted and deeply disruptive. Clinical studies provide objective, measurable insights into whether a product delivers on its promises. Endora’s commitment to research ensures that their supplement is not just well-formulated, but truly effective.
